945995-99-3

Basic information

• Product Name: methyl 3-(4-(2-cyano-4-fluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate
• Synonyms: methyl 3-(4-(2-cyano-4-fluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate
• CAS NO: 945995-99-3
• Molecular Weight: 485.309
• Mol File: 945995-99-3.mol
• Article Data: 1

Chemical Properties

• CAS DataBase Reference: methyl 3-(4-(2-cyano-4-fluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 3-(4-(2-cyano-4-fluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate(945995-99-3)
• EPA Substance Registry System: methyl 3-(4-(2-cyano-4-fluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate(945995-99-3)

Safety Data

• Hazardous Substances Data: 945995-99-3(Hazardous Substances Data)

Upstream product

• 1033909-28-2 methyl 3-(3-bromo-4-hydroxy-6-methyl-2-oxopyridin-1(2H)-yl)-4-methylbenzoate 
• 217661-27-3 2-(bromomethyl)-5-fluorobenzonitrile 

Relevant articles and documents

PYRIDINONE PYRAZOLE UREA AND PYRIMIDINONE PYRAZOLE UREA DERIVATIVES

This invention is directed generally to substituted pyridinone and pyrimidinone compounds that generally inhibit p38 kinase, TNF, and/or cyclooxygeπase activity. Such substituted pyridinone and pyrimidinone compounds include compounds generally corresponding in structure to the following formula: wherein Z, n, R1, R2a, R2b, R2c, R2d, R2e, R3a, R3b R3c, R3d, R4, R5, R6, R7a, R7b, R7c, R7d and R7e are as defined in this specification. This invention also is directed to compositions of such substituted pyridinones and pyrimidinones (particularly pharmaceutical compositions), and methods for treating disorders (typically pathological disorders) associated with p38 kinase activity, TNF activity, and/or cyclooxygenase-2 activity.